Skip to content

A study to evaluate effect of Use of oral jambhavadi kashaya in treating heavy bledding

A RANDOMISED OPEN-LABELLED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF JAMBVADI KASHAYA IN THE MANAGEMENT OF ASRUGDARA WITH SPECIAL REFERENCE TO MENORRHAGIA - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/107188
Enrollment
30
Registered
2026-03-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases

Interventions

None listed

Sponsors

Komal Gaikwad
Lead Sponsor
Sri Sri College of Ayurvedic Science and Research
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Subjects between the age group of 18 to 45 years irrespective of marital status Subjects with classical symptoms of Asrugdara Rakta Atipravritti Ritou Atiprasangen Deerghakala Raktapravritti Deerghakalanubandhen Subjects with Menorrhagia Cyclical Bleeding at normal intervals which is excess in amount or duration Subjects willing to do self assessment Pictorial Blood Assessment Chart PBAC Subjects willing to sign the consent form Subject with seedling fibroid and size less than 5cm

Exclusion criteria

Exclusion criteria: Subjects with known case of bleeding disorders and malignancy Subjects with IUCD Subjects with Pelvic inflammatory disease Subjects with Post-Menopausal Bleeding Subjects with Hb less than 10g per dl Subjects with other systemic illness like uncontrolled diabetes and mental disorder Subjects with Polyp Adenomyosis Endometriosis Subjects with Injury poisoning or certain other consequences of external causes Complications of pregnancy childbirth and the puerperium

Design outcomes

Primary

MeasureTime frame
Significant decrease in excessive blood loss and prolonged blood loss during menstruation, associated with pain and body ache assessed based on PBAC Scoring System, subjective and objective parameters.Timepoint: Pre assessment 0th day 1st assessment 1st cycle after treatment 2nd assessment 2nd cycle after treatment 3rd assessment 3rd cycle without medication

Secondary

MeasureTime frame
1)Generation of in - depth analyzed data on the different aspect of the disease. 2)Generation of data on possible unexpected drug reaction.Timepoint: 1)1 Year 2) 1 year

Countries

India

Contacts

Public ContactDr komal raghunandan gaikwad

Sri Sri College of Ayurvedic Science and Research

rampursspatil@gmail.com9742193553

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026